Yinqi Tiaozhi Decoction ameliorates hepatic steatosis in metabolic dysfunction-associated fatty liver disease by regulating the miR-122-5p/FOXO3 axis to modulate lipid metabolism and oxidative stress
Introduction: Metabolic dysfunction-associated fatty liver disease (MAFLD) lacks targeted pharmacotherapies. Objective: This study investigates whether Yinqi Tiaozhi Decoction (YQTZD) alleviates MAFLD via the miR-122-5p/forkhead box O3 (FOXO3) axis. Methods: MAFLD was modeled using oleic acid–treated AML12 cells and ra...